← Back to headlines
Teva CEO discusses drug pipeline and NYSE direct listing
The CEO of Teva Pharmaceuticals provided insights into the company's drug pipeline and discussed the potential for a direct listing on the New York Stock Exchange.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
